Henghui Zhang

4.0k total citations · 1 hit paper
111 papers, 2.5k citations indexed

About

Henghui Zhang is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Henghui Zhang has authored 111 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 32 papers in Immunology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Henghui Zhang's work include Cancer Immunotherapy and Biomarkers (44 papers), Immunotherapy and Immune Responses (17 papers) and Colorectal Cancer Treatments and Studies (14 papers). Henghui Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (44 papers), Immunotherapy and Immune Responses (17 papers) and Colorectal Cancer Treatments and Studies (14 papers). Henghui Zhang collaborates with scholars based in China, United States and Ethiopia. Henghui Zhang's co-authors include Caicun Zhou, Shengxiang Ren, Lai Wei, Yuanlin Song, Tao Shi, Hongsong Chen, Tao Jiang, Jia Wei, Jie Hu and Xingwang Xie and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Henghui Zhang

109 papers receiving 2.5k citations

Hit Papers

Single-cell transcriptome analysis reveals the associatio... 2024 2026 2025 2024 40 80 120

Peers

Henghui Zhang
Henghui Zhang
Citations per year, relative to Henghui Zhang Henghui Zhang (= 1×) peers Naoya Ikeda

Countries citing papers authored by Henghui Zhang

Since Specialization
Citations

This map shows the geographic impact of Henghui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henghui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henghui Zhang more than expected).

Fields of papers citing papers by Henghui Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henghui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henghui Zhang. The network helps show where Henghui Zhang may publish in the future.

Co-authorship network of co-authors of Henghui Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Henghui Zhang. A scholar is included among the top collaborators of Henghui Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henghui Zhang. Henghui Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xueying, Xi Jiao, Ying Hu, et al.. (2024). Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for ImmunoTherapy of Cancer. 12(2). e006616–e006616. 15 indexed citations
2.
Wang, Shuhang, Beibei Mao, Ning Li, et al.. (2022). Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade. npj Precision Oncology. 6(1). 2–2. 21 indexed citations
3.
Wu, Xueying, Chenyang Zhang, & Henghui Zhang. (2022). Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer. Current Oncology. 29(1). 283–293. 1 indexed citations
4.
Liu, Xuefei, Yanping Xu, Xueying Wu, et al.. (2022). Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis. Frontiers in Immunology. 13. 844914–844914. 3 indexed citations
5.
Liu, Xiaoli, Guanxiong Zhang, Junyan Han, et al.. (2021). A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer. Cancer Immunology Research. 9(3). 337–347. 10 indexed citations
6.
Chen, Yu, Zhi Xie, Jie Jiang, et al.. (2021). High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer. Thoracic Cancer. 12(19). 2564–2573. 9 indexed citations
7.
Wang, Yong, Dandan Liang, Jimin Chen, et al.. (2020). Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma. The Oncologist. 26(3). 173–177. 28 indexed citations
8.
Ren, Xiaohui, Jing Li, Xia Zhang, et al.. (2020). Histological transformation of lung adenocarcinoma to small cell lung cancer with mutant C797S conferring acquired resistance to osimertinib. Journal of International Medical Research. 48(6). 1220727470–1220727470. 14 indexed citations
9.
Hu, Ying, Huaibo Sun, Henghui Zhang, & Xianbo Wang. (2020). An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 10. 1189–1189. 9 indexed citations
10.
Jiang, Tao, Ruirui Cheng, Yuanwei Pan, et al.. (2020). Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer. Translational Lung Cancer Research. 9(2). 246–256. 23 indexed citations
11.
Chen, Huan, Keyan Yang, Guanxiong Zhang, et al.. (2020). Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy. Biomedicine & Pharmacotherapy. 129. 110457–110457. 25 indexed citations
12.
Jiang, Tao, Tao Shi, Henghui Zhang, et al.. (2019). Tumor neoantigens: from basic research to clinical applications. Journal of Hematology & Oncology. 12(1). 277 indexed citations
13.
Zhang, Henghui, Willem A. Kernkamp, Kerong Dai, et al.. (2019). Relations between the Crowe classification and the 3D femoral head displacement in patients with developmental dysplasia of the hip. BMC Musculoskeletal Disorders. 20(1). 530–530. 6 indexed citations
14.
Zhang, Lei, et al.. (2018). Clinical Outcome and Molecular Analysis of a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Mutation V834L. Journal of Thoracic Oncology. 13(10). e189–e191. 2 indexed citations
15.
Liao, Weijia, Yangjing Zhao, Yanhui Chen, et al.. (2017). IL-10 and IL-10RB gene polymorphisms are correlated with hepatitis B-related hepatocellular carcinoma in the Chinese Han population. Translational Cancer Research. 6(2). 432–440. 2 indexed citations
16.
Chen, Xiaojun, Pengfei Jia, Yiping Wang, et al.. (2017). A surface-based approach to determine key spatial parameters of the acetabulum in a standardized pelvic coordinate system. Medical Engineering & Physics. 52(1). 22–30. 6 indexed citations
17.
Liu, Feng, Zhida Liu, Nan Wu, et al.. (2013). In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells. In Vitro Cellular & Developmental Biology - Animal. 49(7). 537–547. 6 indexed citations
18.
Liu, Xinjuan, Na Gao, Mengtao Li, et al.. (2013). Elevated Levels of CD4+CD25+FoxP3+ T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction. PLoS ONE. 8(6). e64531–e64531. 56 indexed citations
19.
Wang, Yan, Henghui Zhang, Yanhui Chen, et al.. (2012). [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma].. PubMed. 46(6). 527–32. 5 indexed citations
20.
Zhang, Henghui, et al.. (2007). The Functional Evaluation of Dendritic Cell Vaccines Based on Different Hepatitis C Virus Nonstructural Genes. Viral Immunology. 20(4). 553–561. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026